ADVANCED HER2+BREAST CANCER

Clinical trials for ADVANCED HER2+BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED HER2+BREAST CANCER trials appear

Sign up with your email to follow new studies for ADVANCED HER2+BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted drug combo tested to control advanced breast cancer

Disease control Ongoing

This study tested whether adding the drug alpelisib to standard therapy helps control advanced HER2-positive breast cancer that has a specific genetic mutation (PIK3CA). It was a Phase 3 trial for patients whose cancer had not progressed after initial chemotherapy. The study was …

Matched conditions: ADVANCED HER2+BREAST CANCER

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

ADVANCED HER2+BREAST CANCER

Get alerted when new ADVANCED HER2+BREAST CANCER trials appear

Targeted drug combo tested to control advanced breast cancer